Pretreatment with glycyrrhizin seemed to reduce the expression levels of these genes compared to the PC-AKI group (KIM-1 and NGAL; P = 0.020, IL-18; P = 0.001) (Fig. 4A–C). This evidence concerns the gene HAVCR1 and acute kidney injury.